CompletedPHASE2, PHASE3NCT01620138

Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas

Studying Functioning pituitary adenoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Universidade Federal do Rio de Janeiro
Principal Investigator
Mônica R. Gadelha, PhD
Endocrinology Section - Hospital Universitário Clementino Fraga Filho/Federal University of Rio de Janeiro
Intervention
Pasireotide(drug)
Enrollment
21 enrolled
Eligibility
18 years · All sexes
Timeline
20102012

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01620138 on ClinicalTrials.gov

Other trials for Functioning pituitary adenoma

Additional recruiting or active studies for the same condition.

See all trials for Functioning pituitary adenoma

← Back to all trials